Apotea

Apotea's net profit fell 24.4% yoy to SEK 24.4 mil in 2018

By Helgi Analytics - August 11, 2020

Apotea made a net profit of SEK 24.4 mil with revenues of SEK 2,092 mil in 2018, down by 24.4% and up by 36.3%, res...

Apotea's Net Margin fell 44.6% yoy to 1.16% in 2018

By Helgi Analytics - August 11, 2020

Apotea made a net profit of SEK 24.4 mil with revenues of SEK 2,092 mil in 2018, down by 24.4% and up by 36.3%, respectively...

Profit Statement 2016 2017 2018
Sales SEK mil 983 1,535 2,092
EBITDA SEK mil 15.8 57.0 46.1
EBIT SEK mil 14.3 41.6 31.6
Financing Cost SEK mil 0.088 0.018 0.010
Net Profit SEK mil 11.2 32.2 24.4
Balance Sheet 2016 2017 2018
Total Assets SEK mil 150 238 332
Non-Current Assets SEK mil 3.71 18.8 48.9
Current Assets SEK mil 146 220 283
Shareholders' Equity SEK mil 44.5 66.2 70.8
Liabilities SEK mil 105 172 261
Ratios 2016 2017 2018
ROE % 28.7 58.2 35.6
EBITDA Margin % 1.60 3.72 2.20
EBIT Margin % 1.46 2.71 1.51
Net Margin % 1.14 2.10 1.16
Cash Flow 2016 2017 2018
Cash Earnings SEK mil 12.6 47.6 38.8

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2011 2012 2013 2014 2015 2016 2017 2018
income statement                
Sales SEK mil   35.1 108 288 586 983    
EBIT SEK mil   -1.53 4.22 5.14 10.7 14.3    
Net Profit SEK mil   -1.54 4.20 5.05 10.6 11.2    
                   
ROE % ... -39.0 35.7 24.8 37.8 28.7    
EBIT Margin %   -4.35 3.92 1.78 1.83 1.46    
Net Margin %   -4.37 3.90 1.75 1.82 1.14    
Employees ... ... 20.0 ... ... ... ... ...
balance sheet                
Total Assets SEK mil   11.8 32.7 56.3 101 150    
Non-Current Assets SEK mil   2.06 2.19 4.70 4.21 3.71    
Current Assets SEK mil   9.70 30.5 51.6 96.5 146    
                   
Shareholders' Equity SEK mil   5.67 17.9 22.9 33.4 44.5    
Liabilities SEK mil   6.08 14.8 33.4 67.3 105    
Current Liabilities SEK mil   6.08 14.8 33.4 67.3 105    
income statement Unit 2011 2012 2013 2014 2015 2016 2017 2018
income statement                
Sales SEK mil   35.1 108 288 586 983    
EBITDA SEK mil   -0.968 4.86 5.87 12.1 15.8    
Depreciation SEK mil   0.561 0.646 0.726 1.40 1.44    
EBIT SEK mil   -1.53 4.22 5.14 10.7 14.3    
Financing Cost SEK mil   0.008 0.019 0.091 0.066 0.088    
Tax SEK mil ... ... ... ... ... 3.08    
Net Profit SEK mil   -1.54 4.20 5.05 10.6 11.2    
Net Profit Avail. to Common SEK mil   -1.54 4.20 5.05 10.6 11.2    
growth rates                
Total Revenue Growth % ... 189 206 168 103 67.9    
Operating Cost Growth % ... 13.9 185 174 103 68.7    
EBITDA Growth % ... -95.0 -602 20.6 106 30.3    
EBIT Growth % ... -92.2 -376 21.9 108 33.9    
Net Profit Growth % ... -92.2 -373 20.3 111 4.99    
ratios                
ROE % ... -39.0 35.7 24.8 37.8 28.7    
ROA % ... -17.2 18.9 11.3 13.6 8.92    
EBITDA Margin %   -2.75 4.52 2.04 2.07 1.60    
EBIT Margin %   -4.35 3.92 1.78 1.83 1.46    
Net Margin %   -4.37 3.90 1.75 1.82 1.14    
balance sheet Unit 2011 2012 2013 2014 2015 2016 2017 2018
balance sheet                
Receivables SEK mil   0.412 4.75 9.44 8.98 15.7    
Current Assets SEK mil   9.70 30.5 51.6 96.5 146    
Non-Current Assets SEK mil   2.06 2.19 4.70 4.21 3.71    
Total Assets SEK mil   11.8 32.7 56.3 101 150    
                   
Trade Payables SEK mil   5.39 12.8 30.2 60.5 93.9    
Other ST Liabilities SEK mil   0.696 1.99 3.26 6.85 11.2    
Current Liabilities SEK mil   6.08 14.8 33.4 67.3 105    
Other LT Liabilities SEK mil ... 0.001 ... ... ... 0.001    
Liabilities SEK mil   6.08 14.8 33.4 67.3 105    
Share Capital SEK mil   0.659 0.659 0.659 0.694 0.694    
Equity Before Minority Interest SEK mil   5.67 17.9 22.9 33.4 44.5    
Equity SEK mil   5.67 17.9 22.9 33.4 44.5    
growth rates                
Total Asset Growth % ... 92.1 178 72.3 78.7 48.6    
Shareholders' Equity Growth % ... 157 215 28.3 45.6 33.5    
ratios                
Current Ratio   1.59 2.06 1.55 1.43 1.39    
cash flow Unit 2011 2012 2013 2014 2015 2016 2017 2018
cash flow                
Net Profit SEK mil   -1.54 4.20 5.05 10.6 11.2    
Depreciation SEK mil   0.561 0.646 0.726 1.40 1.44    
ratios                
Days Sales Outstanding days   4.28 16.1 12.0 5.60 5.81    
Cash Earnings SEK mil   -0.976 4.85 5.78 12.0 12.6    
other ratios Unit 2011 2012 2013 2014 2015 2016 2017 2018
                 
Employees ... ... 20.0 ... ... ... ... ...
Operating Cost (As % of Sales) %   103 95.5 98.0 97.9 98.4    
Total Revenue Growth (5-year average) % ... ... ... ... ... 141    

Get all company financials in excel:

Download Sample   $19.99

Apotea AB is a Sweden-based operator of an online full-scale pharmacy store. The company's online pharmacy store offers a full range of both prescription and non-prescription drugs for allergy, face, animal, fever and pain, cold, skin and hair, hands and feet, stomach and intestine, mouth and teeth, wound, vitamins and minerals and for various other diseases, enabling customers to meet their pharmaceutical requirements conveniently. The Company was founded in 2003.

Apotea Logo

Finance

Apotea has been growing its sales by 81.0% a year on average in the last 5 years. EBITDA has grown on average by 56.8% a year during that time to total of SEK 46.1 mil in 2018, or 2.20% of sales. That’s compared to 2.33% average margin seen in last five years.

The company netted SEK 24.4 mil in 2018 implying ROE of 35.6% and ROCE of . Again, the average figures were 37.0% and

A PHP Error was encountered

Severity: Warning

Message: Division by zero

Filename: models/Chunks_model.php

Line Number: 505

nan%, respectively when looking at the previous 5 years.

Apotea’s net debt amounted to at the end of 2018, or of equity. When compared to EBITDA, net debt was x,

A PHP Error was encountered

Severity: Warning

Message: Division by zero

Filename: models/Chunks_model.php

Line Number: 505

up when compared to average of nanx seen in the last 5 years.

More Companies in Swedish Retail & Wholesale Sector